title: Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users.
abstract: Twenty-one chlamydospore-forming and germ tube-positive Candida albicans clinical isolates from 15 human immunodeficiency virus (HIV)-positive and 3 HIV-negative patients were examined by two different genetic methods. Multilocus enzyme electrophoresis and hybridization with the C. albicans-specific Ca3 probe showed that such isolates can be split into two genetically distinct groups that can be clearly distinguished. One group mainly contained strains with atypical sugar assimilation patterns and could be distinguished from the other group by the absence of intracellular beta-glucosidase activity. All 13 strains belonging to this group were isolated from the oral cavities of asymptomatic HIV-positive drug users and may be less pathogenic than the eight strains from the other group isolated either from HIV-positive patients with oropharyngeal candidiasis or from HIV-negative patients with invasive candidiasis.
authors.affiliation: Institute of Microbiology, University Hospital, CHUV-BH19SUD, Lausanne, Switzerland.
authors.forename: P
authors.initials: P
authors.lastname: Boerlin
authors.forename: F
authors.initials: F
authors.lastname: Boerlin-Petzold
authors.forename: C
authors.initials: C
authors.lastname: Durussel
authors.forename: M
authors.initials: M
authors.lastname: Addo
authors.forename: J L
authors.initials: JL
authors.lastname: Pagani
authors.forename: J P
authors.initials: JP
authors.lastname: Chave
authors.forename: J
authors.initials: J
authors.lastname: Bille
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000175:diagnosis / Q000382:microbiology*; D002176:Candida albicans / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D002180:Candidiasis, Oral / Q000150:complications* / Q000175:diagnosis / Q000382:microbiology*; D016000:Cluster Analysis; D004798:Enzymes / Q000378:metabolism; D005838:Genotype; D006801:Humans; D010641:Phenotype; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000382:microbiology*; D001617:beta-Glucosidase / Q000378:metabolism
chemical_list: D004798:Enzymes; D001617:beta-Glucosidase